Correlation Between Protagenic Therapeutics and Vitru

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Vitru at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Vitru into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Vitru, you can compare the effects of market volatilities on Protagenic Therapeutics and Vitru and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Vitru. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Vitru.

Diversification Opportunities for Protagenic Therapeutics and Vitru

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Protagenic and Vitru is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Vitru in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitru and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Vitru. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitru has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Vitru go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and Vitru

If you would invest  58.00  in Protagenic Therapeutics on August 26, 2024 and sell it today you would earn a total of  7.00  from holding Protagenic Therapeutics or generate 12.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy2.27%
ValuesDaily Returns

Protagenic Therapeutics  vs.  Vitru

 Performance 
       Timeline  
Protagenic Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Protagenic Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating forward indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Vitru 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitru has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitru is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Protagenic Therapeutics and Vitru Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protagenic Therapeutics and Vitru

The main advantage of trading using opposite Protagenic Therapeutics and Vitru positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Vitru can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitru will offset losses from the drop in Vitru's long position.
The idea behind Protagenic Therapeutics and Vitru pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios